News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Amalya Sargsyan: ESMO23 – Advances in EGFR mutated NSCLC
Photo of Amalya Sargsyan from IMMUNOC.ORG
Oct 25, 2023, 19:02

Amalya Sargsyan: ESMO23 – Advances in EGFR mutated NSCLC

Amalya Sargsyan, Research Fellow at

“ESMO23: Advances in EGFR mutated NSCLC!

MARIPOSA: Amivantamab/Lazertinib vs. Osimertinib
Promising results! In 1L EGFR-mutated NSCLC, Amivantamab + Lazertinib reduced disease progression risk by 30%. PFS: 23.7 vs. 16.6 months.

MARIPOSA2: Option to overcome Osimertinib resistance. Amivantamab+Chemo
HR 0.44! In 2L, PFSvs. Chemo alone: 8.3 vs. 4.2m. Impressive ORR (63%) vs. Chemo (36%). Boosted intracranial PFS.

Note: More AEs.

These findings signal Amivantamab as a significant advancement in NSCLC treatment, offering hope to patients.”

Source: Amalya Sargsyan/LinkedIn

Amalya Sargsyan Amivantamab cancer ESMO23 medical oncology OncoDaily Oncology Research Fellow
Special Coverage
Insight
Dec 21, 2024, 17:34
COTA has announced a partnership with precision oncology pioneer Guardant Health
Blog
Dec 21, 2024, 14:10
Arif Kamal: Ensuring all people have access to the cancer navigation services that will help them live more and better days
Blog
Dec 21, 2024, 14:06
The Accelerate 2025 Annual Conference Agenda Is Here!
Blog
Dec 21, 2024, 14:03
Pioneer the future of discovery and innovation with a fully funded Bicentenary PhD Studentship at The University of Manchester
Blog
Dec 21, 2024, 14:00
NCI Division of Cancer Prevention - DHT Derived Biomarkers and COAs for Remote Monitoring and Endpoint Development
Blog
Dec 21, 2024, 13:51
The ESMO President Letter emphasises the importance of collective action to shape the future of oncology
Blog
Dec 21, 2024, 13:48
Overcoming recurrence: How research is bringing new hope for breast cancer patients - The Institute of Cancer Research
Blog
Dec 21, 2024, 13:46
IARC - Cancer Incidence in Five Continents, Vol XII
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025